RxDoctor Payments Data

John Winchester, MD

Anesthesiology · San Francisco, CANPI 1316147515

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $71,022 of the $111,208 with a category attached, or 63.9%. Avanos Medical accounts for 86.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $88,601 and has fallen 91.8% since, to $7,300 in 2024. Among anesthesiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$111,208in general payments, 2019–2025

Across 85 payments — averaging $1308.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avanos Medical$96K
  • B. Braun Medical Inc.$14K
  • Pacira Pharmaceuticals Incorporated$332
  • Acacia Pharma Inc$193
  • Heron Therapeutics, Inc.$110

What the payments were for

  • Consulting fees$71,02264%
  • Speaking & faculty fees$27,02624%
  • Travel & lodging$11,19710%
  • Food & beverage$1,9622%

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$111,208 in reported general payments places this provider in the 95th percentile of 5,717 anesthesiology providers in California.

See all anesthesiology providers in California

Medicare billing

Part B allowed, 2024
$44,926
Medicare patients
346
Services billed
437

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →